Effects of thyroid hormone withdrawal on natriuretic peptides during radioactive iodine therapy in female patients with differentiated thyroid cancer

References

• Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010;22:395–404.
   PubMed Web of Science ®Google Scholar
• Reiners C, Hanscheid H, Luster M, Lassmann M, Verburg FA. Radioiodine for remnant ablation and therapy of metastatic disease. Nat Rev Endocrinol 2011;7:589–95.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Kim KW, Choi SH, Lim S, Park KU, Park do J, Choi DJ, Jang HC, Cho BY, Park YJ. Endothelial function is not changed during short-term withdrawal of thyroxine in patients with differentiated thyroid cancer and low cardiovascular risk. Yonsei Med J 2010;51:492–8.
   PubMed Web of Science ®Google Scholar
• Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol 2004;29:139–50.
   PubMedGoogle Scholar
• Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, Giardino R, Russo MA, Iervasi G. Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother 2009;63:742–53.
   PubMed Web of Science ®Google Scholar
• Schultz M, Kistorp C, Raymond I, Dimsits J, Tuxen C, Hildebrandt P, Faber J. Cardiovascular events in thyroid disease: a population based, prospective study. Horm Metab Res 2011;43:653–9.
   PubMed Web of Science ®Google Scholar
• Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Åsvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N. Thyroid studies collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012;172:799–809.
   PubMedGoogle Scholar
• Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, Bakker SJ, Dehghan A, Drechsler C, Luben RN, Hofman A, Portegies ML, Medici M, Iervasi G, Stott DJ, Ford I, Bremner A, Wanner C, Ferrucci L, Newman AB, Dullaart RP, Sgarbi JA, Ceresini G, Maciel RM, Westendorp RG, Jukema JW, Imaizumi M, Franklyn JA, Bauer DC, Walsh JP, Razvi S, Khaw KT, Cappola AR, Völzke H, Franco OH, Gussekloo J, Rodondi N, Peeters RP. Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab 2015;100:2181–91.
   PubMed Web of Science ®Google Scholar
• Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 2000;85:1822–7.
   PubMed Web of Science ®Google Scholar
• Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S, Zucchelli GC, Clerico A. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin Chem Lab Med 2004;42:627–36.
   PubMed Web of Science ®Google Scholar
• Hoftijzer HC, Bax JJ, Heemstra KA, Bleeker GB, Delgado V, van der Klaauw AA, Romijn JA, Smit JW, Corssmit EP. Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma. Eur J Clin Invest 2009;39:204–10.
   PubMed Web of Science ®Google Scholar
• Pfister R, Schneider CA. Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?. Clin Chim Acta 2004;349:25–38.
   PubMed Web of Science ®Google Scholar
• Stanciu AE, Vatasescu RG, Stanciu MM, Iorgulescu C, Vasile AI, Dorobantu M. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects. Clin Biochem 2013;46:230–4.
   PubMed Web of Science ®Google Scholar
• Pinelli M, Bindi M, Cassetti G, Moroni F, Pandolfo C, Rosada J, Castiglioni M. Relationship between low T3 syndrome and NT-proBNP levels in non-cardiac patients. Acta Cardiol 2007;62:19–24.
   PubMed Web of Science ®Google Scholar
• Wang F, Pan W, Wang H, Wang S, Pan S, Ge J. Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care 2012;16:R11. Doi: 10.1186/cc11151.
   Google Scholar
• Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. The American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–2014.
   PubMed Web of Science ®Google Scholar
• Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, Edinboro CH, Rosenthal D, Thomas MJ, Wexler JA, Asamoah E, Avram AM, Milas M, Greenlee C. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association taskforce on radioiodine safety. Thyroid 2011;21:335–46.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani M, Hasin Y, Biasucci LM, Giannitsis E, Lindahl B, Koenig W, Tubaro M, Collinson P, Katus H, Galvani M, Venge P, Alpert JS, Hamm C, Jaffe AS. Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2012;33:2001–6.
   PubMed Web of Science ®Google Scholar
• Mueller T, Gegenhuber A, Poelz W, Holtmayer M. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem 2003;49:976–9.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Kusumoto M, Sakai R, Watanabe H, Ihara S, Koike N, Kawana M. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation. Can J Cardiol 2007;23:295–300.
   PubMed Web of Science ®Google Scholar
• Sato M, Mikamo A, Kurazumi H, Suzuki R, Murakami M, Kobayashi T, Yoshimura K, Hamano K. Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease. J Cardiothorac Surg 2013;8:32. DOI: 10.1186/1749-8090-8-32.
   PubMed Web of Science ®Google Scholar
• Koukoulis G, Polymeris A, Tzavara I, Pappas D, Thalassinos N. Normalization of thyroid hormone levels in patients with either hyper- or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels. Hormones (Athens) 2002;1:104–12.
   PubMedGoogle Scholar
• Christ-Crain M, Morgenthaler NG, Meier C, Muller C, Nussbaumer C, Bergmann A, Staub JJ, Muller B. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Med Wkly 2005;135:549–54.
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 2002;12:447–52.
   PubMed Web of Science ®Google Scholar
• Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, Choi NC, Yock TI. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer 2008;62:351–5.
   PubMed Web of Science ®Google Scholar
• Nellessen U, Zingel M, Hecker H, Bahnsen J, Borschke D. Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers? Chemotherapy 2010;56:147–52.
   PubMed Web of Science ®Google Scholar
• D’Errico MP, Grimaldi L, Petruzzelli MF, Gianicolo EA, Tramacere F, Monetti A, Placella R, Pili G, Andreassi MG, Sicari R, Picano E, Portaluri M. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys 2012;82:e239–46.
   PubMedGoogle Scholar
• Wondergem J, Strootman EG, Frolich M, Leer JW, Noordijk EM. Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy. Radiother Oncol 2001;58:295–301.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Cooper DS, Emerson CH, Luster M, Maciel RM, Biscolla RP, Mazzaferri EL, Medeiros-Neto G, Reiners C, Robbins RJ, Robinson BG, Schlumberger M, Yamashita S, Pacini F. Expanding indications for recombinant human TSH in thyroid cancer. Thyroid 2008;18:687–94.
   PubMed Web of Science ®Google Scholar
• Pilli T, Brianzoni E, Capoccetti F, Castagna MG, Fattori S, Poggiu A, Rossi G, Ferretti F, Guarino E, Burroni L, Vattimo A, Cipri C, Pacini F. A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab 2007;92:3542–6.
   PubMed Web of Science ®Google Scholar